News & Analysis as of

New Guidance Regulatory Oversight Canada

Blake, Cassels & Graydon LLP

Peut-être êtes-vous un lobbyiste après tout : publication de nouvelles interprétations plus strictes au fédéral

D’importants changements apportés aux principales interprétations de la commissaire au lobbying du Canada augmenteront considérablement le nombre d’organisations et de personnes morales assujetties à des exigences...more

Stikeman Elliott LLP

Canada Reconsiders Comparative Clinical Trials Requirements for Biosimilars

Stikeman Elliott LLP on

On June 10, 2025, Health Canada initiated a public consultation on proposed revisions to its Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs. A notable update is the proposal to remove...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide